Amphotropic virus receptor
AssigneeAmerican Cyanamid Company
InventorsStephen V. Johann, Marja van Zeijl, Bryan M. O'Hara
Life of this patent
Estimating the term…
Abstract
The present invention relates to an isolated nucleic acid fragment comprising a nucleic acid sequence coding for an amphotropic retrovirus receptor. This receptor is referred to as GLVR2 and has approximately 62% homology with the GLVR1 gene encoding for Gibbon Ape Leukemia Virus (GALV). Differences for the type of retroviruses interacting with the receptors exist. The protein encoding by the GLVR2 gene, cells transformed or transfected by the gene and vectors containing the gene are also disclosed.
Claims2
A recombinantly produced amphotropic virus receptor protein comprising the amino acid sequence as set forth in SEQ ID NO:
- 2.
A recombinantly produced amphotropic virus receptor protein encoded by the nucleic acid molecule having the nucleic acid sequence set forth in SEQ ID NO:
- 1.
Dependencies are inferred from the claim text.